News & Updates

November 18, 2019

CR Medicon Expands Pharmacovigilance Management Capability in China With Oracle Argus

Nanjing, China Nov. 12, 2019 Nanjing CR Medicon Pharmaceutical Technology CO., Ltd., a Gold level member of Oracle […]
April 6, 2020

Webinar: China NMPA and US FDA Emergency Approval and Implications to Life Science Companies Relating to COVID-19

Time: Tue, 07 April 2020 11:00 AM – 12:30 PM (EST) As COVID-19 has become […]
December 26, 2019

China Annual ADR & ADE Monitoring Report (2018)

NMPA released an annual report on ADR & ADE monitoring in China (the 2018 version). […]
December 25, 2019
US-China Clinical Trial

US-China Clinical Trial Regulatory Overview

In this publication, we give a side-by-side comparative overview of clinical trial regulatory commonalities and […]
December 21, 2019
chemical drug

Innovative Chemical Drug Development in China

Compared with generic drugs, the development of innovative chemical drugs is more difficult, expensive, and […]
December 21, 2019
CRO in China

CRO in China – Leading the World with Rapid Growth

In recent years, the CRO (Contract Research Organization) industry in China has entered a “golden […]
October 27, 2019

CR Medicon Participated in 10th China International Medical Device Regulatory Forum (CIMDR)

On September 25-27, 2019, the China Food and Drug International Exchange Center held the 10th […]
September 28, 2019
How to Choose CRO

How to Choose a CRO Company

September 1, 2018

CR Medical Set Up a PK Analysis Lab

To accelerate its progress in biological sample analysis, CR Medicon has built a new bioanalytical […]